Nemaura Medical Inc.

NMRDOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$8070

P/E Ratio—

52W High$0.0005

52W Low$0.00001

Avg Volume585

Open$0.00

Beta0.92

Earnings Financials Revenue

Nemaura Medical Inc. (NMRD) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NMRD · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2024Report Date: Feb 12, 2024

EPS Actual

-$0.12

Est. -$0.12 · +0.0%

Revenue

—

Fiscal Period

Q1 FY2024

FY ends December

Report Date

Feb 12, 2024

After Market Close

✓ 1-Quarter EPS Beat Streak

NMRD reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 10, 2026	-$0.08	—	—	—	$0.00B	—
◌ Q2 FY2026	Jun 3, 2026	-$0.08	—	—	—	—	—
◌ Q2 FY2026	Jun 3, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Feb 27, 2026	-$0.08	—	—	—	$0.00B	—
◌ Q3 FY2025	Sep 29, 2025	—	—	—	—	—	—
◌ Q2 FY2025	Jun 30, 2025	—	—	—	—	—	—
◌ Q2 FY2025	May 30, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Feb 25, 2025	—	—	—	—	—	—

Q3 FY2026

Aug 10, 2026

EPS Actual

—

EPS Est.

-$0.08

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 3, 2026

EPS Actual

—

EPS Est.

-$0.08

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 3, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Feb 27, 2026

EPS Actual

—

EPS Est.

-$0.08

EPS Surpr.

—

Revenue

—

Q3 FY2025

Sep 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

Jun 30, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 30, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 25, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2030	$-0.10	$-0.10	$-0.10	1
Q3 FY2030	$-0.11	$-0.11	$-0.11	1
Q2 FY2030	$-0.11	$-0.11	$-0.11	1
Q1 FY2030	$-0.10	$-0.10	$-0.10	1
Q4 FY2029	$-0.11	$-0.11	$-0.11	1
Q3 FY2029	$-0.11	$-0.11	$-0.11	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2030	$0.0B	$0.0B	$0.0B	1
Q3 FY2030	$0.0B	$0.0B	$0.0B	1
Q2 FY2030	$0.0B	$0.0B	$0.0B	1
Q1 FY2030	$0.0B	$0.0B	$0.0B	1
Q4 FY2029	$0.0B	$0.0B	$0.0B	1
Q3 FY2029	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q1 FY2024	Feb 12, 2024	+0.0%	$0.08	$0.08	-4.82%
▼ Q4 FY2023	Nov 13, 2023	-10.0%	$0.24	$0.24	-2.31%

Q1 FY2024-4.82%

Report Date

Feb 12, 2024

EPS Beat/Miss

+0.0%

Price Before

$0.08

Price After

$0.08

Q4 FY2023-2.31%

Report Date

Nov 13, 2023

EPS Beat/Miss

-10.0%

Price Before

$0.24

Price After

$0.24

Avg Beat Reaction-4.82%

Avg Miss Reaction-2.31%

Beat Rate1 / 2 quarters

Largest Move-4.82% (Q1 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Nemaura Medical Inc. (NMRD) most recently reported earnings on February 12, 2024 for Q1 FY2024, posting EPS of $-0.12 (in line with the analyst consensus of $-0.12). The next NMRD earnings date is expected around September 1, 2026.

Each quarter, investors track NMRD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NMRD revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NMRD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NMRD earnings · 4 questions

Nemaura Medical Inc.'s next earnings report is expected around September 1, 2026. NMRD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NMRD historically reports after market close (AMC).

NMRD earnings datewhen is NMRD earningsNMRD next earnings datewhen does NMRD report earningsNMRD earnings calendar

▸ Source: FMP · Nemaura Medical Inc. SEC filings · US GAAP · Nemaura Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026